Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1997;81:812-823

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamada, H.
Right arrow Articles by Murray, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamada, H.
Right arrow Articles by Murray, P. A.
(Circulation Research. 1997;81:812-823.)
© 1997 American Heart Association, Inc.


Articles

Phenylephrine-Induced Ca2+ Oscillations in Canine Pulmonary Artery Smooth Muscle Cells

Hiroshi Hamada, Derek S. Damron, Sung Jin Hong, David R. Van Wagoner, , Paul A. Murray

From the Center for Anesthesiology Research, Division of Anesthesiology and Critical Care Medicine, The Cleveland (Ohio) Clinic Foundation.

Correspondence to Paul A. Murray, PhD, Carl E. Wasmuth Chair and Director, Center for Anesthesiology Research-FF4, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail murrayp{at}cesmtp.ccf.org


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract Modulation of [Ca2+]i in response to receptor activation is a critical determinant of vascular smooth muscle tone. In this study, we examined the effect of continuous stimulation of {alpha}1-adrenoceptors with phenylephrine (PE) on [Ca2+]i in single pulmonary artery smooth muscle cells (PASMCs) cultured from explants of canine intrapulmonary artery. Fura 2–loaded PASMCs pretreated with propranolol (5 µmol/L) were continuously superfused with PE at 37°C on the stage of an inverted fluorescence microscope, and [Ca2+]i was measured using a dual-wavelength spectrofluorometer. Resting values of [Ca2+]i were 96±4 nmol/L. PE (10 µmol/L) stimulated oscillations in [Ca2+]i at a frequency of 1.35±0.07/min, which reached a peak [Ca2+]i of 650±26 nmol/L (n=69 cells). The oscillations lasted for >30 minutes and were constant in amplitude and frequency. Both the amplitude and frequency of PE-induced [Ca2+]i oscillations increased in a dose-dependent (3x10-8 to 10-4 mol/L) manner. Pretreatment with the {alpha}1-adrenoceptor antagonist prazosin (50 nmol/L) or removal of extracellular Ca2+ abolished the repetitive [Ca2+]i oscillations induced by PE. The voltage-operated Ca2+ channel blockers nifedipine (1 µmol/L) and verapamil (1 µmol/L) had no effect on the [Ca2+]i oscillations. In contrast, inhibition of phospholipase C with U73122 (10-7 to 10-5 mol/L) attenuated the oscillations in a dose-dependent fashion. The nonselective protein kinase inhibitor staurosporine (10-9 to 10-7 mol/L) had a minimal inhibitory effect on the oscillations. Caffeine (30 mmol/L) and thapsigargin (1 µmol/L) abolished the oscillations, whereas pretreatment with ryanodine (1 to 100 µmol/L) had no effect. In freshly dispersed PASMCs, PE (10 µmol/L) induced oscillations in [Ca2+]i similar to those observed in cultured cells, and patch-clamp experiments revealed oscillations in membrane potential. These results indicate that PE induces [Ca2+]i oscillations in PASMCs via stimulation of {alpha}1-adrenoceptors coupled to phospholipase C activation. Voltage-operated Ca2+ channels and protein kinases are not required for the oscillations. The requirement for extracellular Ca2+ and intracellular Ca2+ stores indicates that both Ca2+ influx and intracellular Ca2+ release play a role in the maintenance of the oscillations.


Key Words: Ca2+ • pulmonary artery • {alpha}-adrenoceptor • phospholipase C


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
An increase in [Ca2+]i plays a primary role in triggering contraction of vascular smooth muscle cells. Increases in [Ca2+]i result from an influx of Ca2+ across the sarcolemma and/or release of Ca2+ from intracellular stores. Although K+ channels play an important role in the maintenance of steady state vasomotor tone,1 2 agonists capable of increasing [Ca2+]i in smooth muscle cells are important for the acute modulation of vasomotor tone in response to neural, humoral, and local activation.

Sympathetic {alpha}1-adrenoceptors on smooth muscle cells are G protein–coupled receptors that mediate contraction by increasing [Ca2+]i.3 These receptors are linked to the activation of phospholipase C, which hydrolyzes polyphosphatidylinositol 4,5-bisphosphate to IP3 and DG.4 IP3 can mobilize Ca2+ from intracellular stores to increase [Ca2+]i, whereas DG can stimulate PKC,5 which may be involved in the maintenance of sustained contractions. The increase in [Ca2+]i due to mobilization of Ca2+ from intracellular stores by IP3 is transient because of the limited storage capacity of intracellular pools as well as the concomitant activation of membrane Ca2+ pumps, which restore [Ca2+]i to resting levels. Repetitive oscillations in [Ca2+]i in response to agonist stimulation have been demonstrated in several types of smooth muscle, which suggests that Ca2+ could exert its action through a frequency-dependent mechanism.6 7

In the pulmonary circulation, {alpha}1-adrenoceptor activation causes vasoconstriction in vivo.8 In isolated pulmonary arterial rings, increases in developed tension induced by {alpha}1-adrenoceptor agonists are potentiated by removal of the endothelium.9 Therefore, acute changes in pulmonary vasomotor tone result from a balance between stimuli causing smooth muscle contraction and endothelium-derived vasoactive factors causing relaxation.10 Such interactions between endothelium and vascular smooth muscle make it difficult to assess the direct effects of vasoactive agents on Ca2+ signaling and smooth muscle cell contraction. Little is known about the direct effects of {alpha}1-adrenoceptor stimulation on [Ca2+]i in the pulmonary circulation at the cellular level. In the present study, we examined the direct effects of the {alpha}1-adrenoceptor agonist phenylephrine on [Ca2+]i at the single-cell level, in cultures of canine pulmonary arterial myocytes. PE stimulated persistent oscillations in [Ca2+]i that were dependent on the presence of extracellular Ca2+ but did not require activation of VOCs. The amplitude and frequency of the oscillations increased in a dose-dependent manner with increasing concentrations of PE. The maintenance of the oscillations also depended on caffeine-sensitive intracellular stores of Ca2+ but did not involve Ca2+ release via the ryanodine release channel or the activation of protein kinases. We also observed PE-induced oscillations in [Ca2+]i and membrane potential in freshly dispersed pulmonary artery smooth muscle cells. Oscillations in [Ca2+]i in response to {alpha}1-adrenoceptor activation may provide a frequency-dependent Ca2+ signal for acute modulation of pulmonary vasomotor tone.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animals
Pulmonary arteries were isolated from adult male mongrel dogs. The technique of euthanasia was approved by the Institutional Animal Care and Use Committee. All steps were performed aseptically under general anesthesia (20 µg/kg IV fentanyl and 30 mg/kg IV pentobarbital sodium), with endotracheal intubation and positive-pressure ventilation. The dogs were killed by removing the mobilizable blood volume, followed by the administration of saturated KCl (30 mL). A thoracotomy was performed via the left fifth intercostal space. The heart and lungs were removed en bloc, and pulmonary arteries were isolated and dissected in a laminar flow hood under sterile conditions.

Cell Culture of PASMCs
Primary cultures of smooth muscle cells were obtained from segmental and subsegmental branches of the pulmonary artery (the third and fourth generation of branches from the main pulmonary artery having diameters of <4 mm). The intralobar arteries were carefully dissected and prepared for tissue culture. Explant cultures were prepared according to the method of Campbell and Campbell11 with minor modifications. Briefly, the endothelium was removed by gently rubbing with a sterile cotton swab. The tunica adventitia was carefully removed, together with the most superficial part of the tunica media. The remaining part of the media was cut into 2-mm2 pieces that were explanted in 25-cm2 culture flasks. The explants were nourished by DMEM/F-12 medium containing 10% FBS and 1% antibiotic-antimycotic mixture solution (10 000 U/mL penicillin, 10 000 µg/mL streptomycin, and 25 µg/mL amphotericin B) and kept in a humidified atmosphere of 5% CO2/95% air at 37°C. PASMCs began to proliferate from explants after 7 days in culture. Cells were allowed to grow for an additional 7 to 10 days until subconfluence was achieved. Cells were then subcultured nonenzymatically to 75-cm2 culture flasks and/or 35-mm glass dishes specially designed for fluorescence microscopy (Bioptechs {Delta}T system). Cells were used for experimentation within 72 hours.

Immunolabeling of PASMCs With Smooth Muscle {alpha}-Actin
Confluent PASMCs were washed in PBS (three times for 5 minutes each) and then rapidly fixed in absolute acetone (-20°C) for 10 minutes. Fixed cells were rehydrated by washing in PBS (twice for 10 minutes) and then incubated with a fluorescein-labeled antibody against smooth muscle {alpha}-actin (10 µg/mL, Sigma Chemical Co) for 2 hours at room temperature. Unbound antibody was removed by washing in PBS (twice for 10 minutes). Cells were costained with propidium iodide (20 µg/mL, Molecular Probes) for 1 hour at room temperature to localize the nucleus. Coverslips were mounted on glass slides using Vectashield (Vector Labs), and photomicrographs were taken on a Nikon Optiphot fluorescence microscope using Kodak PPF 400 color print film.

Freshly Dispersed PASMCs
PASMCs were isolated using a modification of the dispersion procedure described by Albarwani et al.12 The isolated lungs were stored at room temperature in solution A (TableDown). Pulmonary arteries were rapidly dissected and stored briefly ({approx}30 minutes) at 4°C in this solution. A segment ({approx}5 cm) of pulmonary artery was opened with surgical scissors, and the endothelium was removed by gently rubbing the surface with a cotton swab. The tissue was then transferred to a 15-mL centrifuge tube containing 10 mL of the initial digestion solution (solution B) supplemented with 15 mg papain (14 U/mg) and 10 mg dithiothreitol. The tissue was placed in this solution for 15 minutes at 4°C and then transferred to a shaking water bath (37°C) for 6 minutes. The tissue was then removed and minced into 1-cm segments. The minced tissue was placed in a 125-mL Erlenmeyer flask containing 10 mL of solution B supplemented with 0.75 mg/mL collagenase (Worthington type I, 307 U/mg), 0.5 mg/mL trypsin inhibitor (Sigma type II), and 10 mmol/L butanedione monoxime. The minced tissue was shaken in this solution in the water bath for 6 minutes. The tissue and solution were then triturated three or four times with a plastic transfer pipette and transferred to a plastic beaker. Fresh collagenase solution (10 mL) was added to the Erlenmeyer flask. The tissue was transferred back into the fresh collagenase solution, and the first digestion solution (containing the released PASMCs) was gently centrifuged ({approx}10g) for 1 minute. The supernatant (8 mL) was aspirated and discarded, and the remaining 2 mL was washed and resuspended in solution C, supplemented with 1% BSA (Sigma fraction V). The tissue digestion procedure was repeated three or four times. The PASMCs were maintained in solution C at room temperature and gassed with 100% O2 until they were studied (within 2 to 5 hours of isolation). Yields of spindle-shaped PASMCs were in the range of 10% to 30%. All chemicals and enzymes were obtained from Sigma, except the collagenase. All plastic and glassware were pretreated with Sigmacote.


View this table:
[in this window]
[in a new window]
 
Table 1. Solutions

Patch-Clamp Recordings in PASMCs
Conventional whole-cell recording techniques were used to measure voltage-gated Ca2+ currents in freshly dispersed PASMCs. Aliquots of the cell suspension were transferred to a 35-mm dish on the stage of an inverted microscope, maintained at a temperature of 35°C (Bioptech's {Delta}T system), and gassed with 100% O2. Cells were superfused (1 to 2 mL/min) with a control cell bath (solution D). Sylgard-coated low-resistance (2- to 3-M{Omega}) electrodes were filled with a CsCl pipette solution (solution E). Data acquisition was performed with pClamp 6.0 software controlling an Axopatch 200A amplifier (Axon Instruments). Whole-cell currents were recorded from a holding potential of -50 mV (to inactivate voltage-dependent Na+ current). Once stable control current recordings were obtained, the superfusion solution was switched to one containing 10 µmol/L nifedipine. Leak current was corrected by digitally subtracting the current after nifedipine exposure from the control current recording. Current densities (pA/pF) were obtained by dividing current amplitudes by the capacitance value. Series resistance values were typically in the range of 5 to 6 M{Omega} and were not corrected.

Current-clamp experiments were performed using the nystatin–perforated patch technique. The experimental setup was nearly identical to that used to record Ca2+ currents; however, recordings were obtained using an Axopatch 1C amplifier in the current-clamp mode. Sylgard-coated low-resistance electrodes were front-filled with a pipette solution (solution F) by capillary action and then back-filled with a similar solution to which nystatin (final concentration, 100 mg/mL) had been added from a stock solution made fresh daily. Once nystatin was added to the buffer, the pipette solution was sonicated (30 seconds) and used within 3 hours. After a stable seal was formed in the voltage-clamp mode, the amplifier was switched to current-clamp mode. Membrane potential was monitored and recorded using Axotape software (Axon Instruments).

Fura 2–Loading Procedure
Twenty-four hours before experimentation, the culture medium containing 10% FBS was substituted for the serum-free medium to arrest cell growth, allow for establishment of steady state cellular events independent of cell division, and prevent a false estimate of [Ca2+]i due to binding of available dye by a high serum protein concentration in the medium.13 PASMCs were washed twice in LB, which contained (mmol/L) NaCl 125, KCl 5, MgSO4 1.2, glucose 11, CaCl2 1.8, and HEPES 25, plus 0.2% BSA, at pH 7.40 adjusted with NaOH. PASMCs were then incubated in LB containing 2 µmol/L fura 2-AM, the acetoxymethyl derivative of fura 2 (Molecular Probes), at ambient temperature for 30 minutes. After the 30-minute loading period, the cells were washed twice in LB and incubated at ambient temperature for an additional 20 minutes before the study. This provided sufficient time to wash away any extracellular fura 2-AM and for intracellular esterases to cleave fura 2-AM into the active fura 2.14

Freshly dispersed PASMCs were loaded with fura 2-AM in a similar fashion. Freshly dispersed PASMCs were washed twice with LB and then incubated with LB containing fura 2-AM (2 µmol/L) at room temperature for 30 minutes. Cells were washed twice with LB (twice for 10 minutes) to remove extracellular fura 2-AM.

Determination of [Ca2+]i
Culture dishes containing fura 2–loaded PASMCs were placed in a temperature-regulated (37°C) chamber (Bioptechs, Inc) mounted on the stage of an Olympus IX-70 inverted fluorescence microscope. Fluorescence measurements were performed on individual smooth muscle cells in a culture monolayer or in freshly dispersed cells using a dual-wavelength spectrofluorometer (Deltascan RFK6002, Photon Technology Intl) at excitation wavelengths of 340 and 380 nm and an emission wavelength of 510 nm. The volume of the chamber was 1.5 mL. The cells were superfused continuously at 1 mL/min with Krebs-Ringer buffer, which contained (mmol/L) NaCl 125, KCl 5, MgSO4 1.2, glucose 11, CaCl2 2.5, and HEPES 25, at pH 7.40 adjusted with NaOH. The temperature of all solutions was maintained at 37°C in a water bath. Solution changes were accomplished rapidly by aspirating the buffer in the dish and transiently increasing the flow rate to 10 mL/min. Just before data acquisition, background fluorescence was obtained and subtracted automatically from the subsequent experimental measurement. Fura 2 fluorescence signals (340, 380, and 340/380 ratio) originating from individual PASMCs were continuously monitored at a sampling frequency of 25 Hz and were collected and stored using a software package from Photon Technology Intl (Felix).

Fura 2 Titration
Estimations of [Ca2+]i were achieved by comparing the cellular fluorescence ratio with fluorescence ratios acquired using fura 2 (free acid) in buffers containing known [Ca2+]. [Ca2+]i was calculated as described by Grynkiewicz et al.15

Data Analysis
The amplitude and frequency of PE-induced increases in [Ca2+]i were measured in individual PASMCs. Amplitude was calculated by averaging the peak ratio value obtained for each oscillation before and after the intervention (four or five oscillations). The change in the 340/380 fluorescence ratio was then calculated by subtracting the resting ratio value (baseline). Changes in the amplitude of the 340/380 fluorescence ratio after interventions were also expressed as percentage of control. PASMCs began to oscillate [Ca2+]i in response to PE at a concentration of 3x10-8 mol/L, so the amplitude and frequency of the oscillations at this concentration were considered the control response and were defined as 100% of control. Frequency of oscillations was calculated by averaging the time interval between the oscillation peaks and is reported as the number of oscillations observed per minute. Results are expressed as mean±SEM. Statistical analysis was performed using repeated-measures ANOVA followed by Bonferroni/Dunn post hoc testing. Differences were considered statistically significant at P<.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Immunolabeling With Smooth Muscle {alpha}-Actin
Indirect immunofluorescent staining of the cultured PASMCs demonstrates the characteristic lace and longitudinal fluorescent patterns of smooth muscle cell actin filaments (Fig 1Down). Propidium iodide was used to identify the nucleus. For the first through third subcultured passages, canine PASMCs were >99% pure, as determined with indirect immunofluorescent staining.



View larger version (137K):
[in this window]
[in a new window]
 
Figure 1. Cultured PASMCs show positive staining for smooth muscle {alpha}-actin. Propidium iodide was used to label the nucleus. Magnification x400.

Effect of {alpha}1-Adrenoceptor Stimulation With PE on [Ca2+]i in PASMCs
Resting values of [Ca2+]i were 96±4 nmol/L. PASMCs were pretreated with the ß-adrenoceptor antagonist propranolol (5 µmol/L) to eliminate any ß-agonist effect of PE. Continuous superfusion of PE (10-5 mol/L), known to be a maximally effective concentration,16 17 stimulated repetitive [Ca2+]i oscillations at a frequency of 1.35±0.07 transients/min for >30 minutes (Fig 2Down, top). The [Ca2+]i reached an average peak value of 650±26 nmol/L. Both amplitude and frequency of the [Ca2+]i oscillations in response to PE were dose dependent (Fig 2Down, bottom; n=10 cells). The amplitude of the individual [Ca2+]i oscillations reached a plateau at a concentration of 10-5 mol/L PE (265±26% of control), whereas the frequency was still increasing even at 10-4 mol/L PE (348±14%). The frequency and amplitude of PE-induced [Ca2+]i oscillations were similar in cells through the third passage.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 2. Effect of PE on [Ca2+]i in individual PASMCs. Top, A representative trace demonstrating that PE (10 µmol/L) stimulated persistent oscillations in [Ca2+]i lasting >30 minutes. PE was added to the superfusion buffer at the arrow. Bottom, Summarized data depicting the dose-dependent increases in both amplitude and frequency of [Ca2+]i oscillations induced by PE (n=10 cells).

Effect of {alpha}1-Adrenoceptor Inhibition With Prazosin
To determine whether the [Ca2+]i oscillations were mediated by {alpha}1-adrenoceptor activation, the {alpha}1-adrenoceptor antagonist prazosin (50 nmol/L) was added to the superfusate after induction of [Ca2+]i oscillations in response to PE (10 µmol/L). Prazosin completely abolished PE-induced [Ca2+]i oscillations (Fig 3Down, n=14 cells).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. A representative trace demonstrating the effect of the {alpha}1-adrenoceptor antagonist prazosin on [Ca2+]i oscillations induced by PE (10 µmol/L). Prazosin (50 nmol/L) was added to the superfusion buffer as indicated.

Effect of Removal of Extracellular Ca2+
We examined the extent to which extracellular Ca2+ contributed to PE-induced [Ca2+]i oscillations in PASMCs. After initiation of PE-induced (10 µmol/L) [Ca2+]i oscillations, PE-containing buffer was washed out and replaced with Ca2+-free Krebs-Ringer buffer containing EGTA (100 µmol/L). After 3 minutes of incubation in the absence of extracellular Ca2+, PE was added back to the superfusion buffer. Although in some cells PE stimulated several transient oscillations in [Ca2+]i (Fig 4Down, top), sustained oscillations were not observed in the absence of extracellular Ca2+ (n=16 cells). Readdition of Ca2+ to the superfusion buffer in the presence of PE resulted in an immediate recovery of the repetitive [Ca2+]i oscillations (Fig 4Down, top).



View larger version (38K):
[in this window]
[in a new window]
 
Figure 4. Requirement of extracellular Ca2+ for the [Ca2+]i oscillations induced by PE. Top, A representative trace depicting the effect of PE (10 µmol/L) on [Ca2+]i oscillations following removal of extracellular Ca2+. Repetitive [Ca2+]i oscillations were abolished when the external Ca2+ was removed (Ca2+-free buffer plus 100 µmol/L EGTA). [Ca2+]i oscillations returned when Ca2+ was added back to the superfusate. Bottom, Summarized data depicting the effect of voltage-operated Ca2+ channel blockers nifedipine (NIF, 1 µmol/L) or verapamil (VER, 1 µmol/L) on [Ca2+]i oscillations induced by PE (10 µmol/L) compared with control (CTRL). [Ca2+]i oscillations persisted in the presence of NIF or VER (n=16 cells).

Effect of Voltage-Operated Ca2+ Channel Blockers
To examine whether the requirement of extracellular Ca2+ for the PE-induced [Ca2+]i oscillations involved activation of VOCs, the L-type VOC antagonists, verapamil or nifedipine, were added to the superfusate in the presence of PE. Neither verapamil (1 µmol/L) nor nifedipine (1 µmol/L) altered the amplitude or frequency of the PE-induced (10 µmol/L) [Ca2+]i oscillations (Fig 4Up, bottom; n=16 cells).

Effect of {alpha}1-Adrenoceptor Stimulation With PE on [Ca2+]i and Membrane Potential in Freshly Dispersed PASMCs
In order to determine whether the Ca2+ oscillations induced by PE in the cultured cells were also present in "native" cells, we developed a method for isolating freshly dispersed, Ca2+-tolerant, spindle-shaped PASMCs. These cells are more suitable for patch-clamp analysis and allowed us to examine electrophysiological changes in response to {alpha}1-adrenoceptor activation with PE. A representative myocyte isolated with this protocol is shown in Fig 5ADown. Resting values of [Ca2+]i were 75±8 nmol/L in freshly dispersed PASMCs (n=9 cells). Exposure to PE (10 µmol/L) resulted in [Ca2+]i oscillations at a frequency of 0.89±0.09 transients/min, and the average peak value of [Ca2+]i reached 293±13 nmol/L (Fig 5BDown). Nifedipine (10 µmol/L) had no effect on PE-induced [Ca2+]i oscillations in these freshly dispersed PASMCs.



View larger version (50K):
[in this window]
[in a new window]
 
Figure 5. In freshly dispersed PASMCs, PE initiates oscillations in [Ca2+]i and membrane potential. A, A typical myocyte isolated from canine pulmonary artery using the dispersion protocol outlined in "Materials and Methods" is shown. B, [Ca2+]i oscillations in freshly dispersed myocytes are qualitatively similar to those observed in cultured PASMCs. C, Application of PE (10 µmol/L) to a PASMC monitored under current-clamp conditions causes a depolarization and initiation of rapid oscillations in membrane potential (Em).

We also measured the effects of PE on membrane potential in freshly dispersed PASMCs. The mean resting potential was -45±3 mV (n=16) before the addition of PE. Addition of PE (10 µmol/L) caused a rapid depolarization followed by oscillations in membrane potential (Fig 5CUp). Nifedipine (10 µmol/L) had no effect on the PE-induced oscillations in membrane potential. The effects of PE on [Ca2+]i oscillations (Fig 5BUp) and membrane potential (Fig 5CUp) were measured in separate experiments from cells isolated from the same lung.

We also performed experiments in the freshly dispersed PASMCs to determine whether dihydropyridine-sensitive Ca2+ currents were present. Fig 6Down illustrates typical Ca2+ currents recorded from an isolated, freshly dispersed PASMC before and after superfusion with 10 µmol/L nifedipine. Similar recordings were obtained in six additional freshly dispersed PASMCs. Peak current density was measured in each myocyte and normalized to myocyte capacitance. The mean peak Ca2+ current density was -2.06±0.54 pA/pF (n=7), with a mean capacitance of 15±2 pF.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 6. L-type Ca2+ currents are present in freshly dispersed PASMCs. A, Raw current traces recorded from a holding potential of –50 mV using 75-millisecond voltage steps to potentials ranging between –40 and +30 mV, in 10-mV increments, applied at 3-second intervals. B, Currents elicited in the same PASMC using the same voltage-clamp protocol after 2-minute superfusion with 10 µmol/L nifedipine. C, Nifedipine-sensitive current obtained by subtracting the current recorded after nifedipine treatment from the current obtained before nifedipine was added to the bath. D, Current-voltage relationship for the inward Ca2+ current before ({blacksquare}) and after ({bullet}) application of nifedipine to the bath.

Effect of Phospholipase C Inhibition
The activation of {alpha}1-adrenoceptors generates two intracellular messengers, IP3 and DG, via a G protein–dependent phospholipase C transduction pathway.4 We used U73122, an inhibitor of the phospholipase C family,18 to investigate the link between PE-induced (10 µmol/L) [Ca2+]i oscillations and the formation of IP3 and DG in PASMCs. U73122 caused dose-dependent inhibition of both amplitude and frequency of PE-induced [Ca2+]i oscillations (Fig 7Down, top and bottom). Thapsigargin increases [Ca2+]i by decreasing its uptake into the SR via inhibition of the Ca2+-ATPase.19 Addition of thapsigargin following pretreatment with U73122 caused a rapid increase in [Ca2+]i, indicating that the inhibitory effect of U73122 was not due to interference with the storage or release of Ca2+ from intracellular stores (Fig 7Down, top; n=13 cells).



View larger version (32K):
[in this window]
[in a new window]
 
Figure 7. Effect of phospholipase C inhibition with U73122 on [Ca2+]i oscillations induced by PE. Top, A representative trace depicting the dose-dependent inhibitory effect of U73122 on [Ca2+]i oscillations induced by PE (10 µmol/L). Increasing concentrations of U73122 (0.1 to 10 µmol/L) were added to the superfusion buffer (indicated by the down arrows) in the continued presence of PE. The SR Ca2+-ATPase inhibitor thapsigargin (Tg) was added to demonstrate the presence of intracellular Ca2+ stores during U73122 treatment. Bottom, Summarized data showing the dose-dependent inhibitory effect of U73122 on both amplitude and frequency of the [Ca2+]i oscillations induced by PE (n=13 cells).

Effect of Protein Kinase Inhibition
The inhibitory effect of U73122 suggests that IP3 and/or DG is likely to play a key role in PE-induced Ca2+ oscillations in PASMCs. IP3 mobilizes Ca2+ from the SR, whereas DG activates PKC. We used staurosporine, a potent nonselective inhibitor of protein kinases, to examine the extent to which protein kinase activation is involved in regulating [Ca2+]i oscillations induced by PE. Fig 8Down demonstrates that staurosporine inhibits both the amplitude and frequency of PE-induced [Ca2+]i oscillations in the range of 3 to 100 nmol/L (IC50 for PKC, 8 nmol/L).20 However, the inhibitory effect of staurosporine was small, even at the highest concentration used in the present study (amplitude, 88±2%; frequency, 92±2% of control values; n=12 cells).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 8. Summarized data showing the effect of the nonselective protein kinase inhibitor staurosporine on [Ca2+]i oscillations induced by PE. Increasing concentrations of staurosporine were added to the superfusate in the continued presence of 10 µmol/L PE (n=12 cells).

Role of SR Ca2+
IP3, another intracellular second messenger in the phospholipase C signal transduction pathway, increases [Ca2+]i by stimulating Ca2+ release from the SR via the IP3 receptor. In addition, Ca2+ influx from extracellular sources can trigger SR Ca2+ release via the ryanodine receptor by a process known as Ca2+-induced Ca2+ release. We examined the role of the SR in PE-induced [Ca2+]i oscillations. Caffeine and ryanodine were used as tools to study SR Ca2+ release pathways and to investigate the role of the SR in PE-induced [Ca2+]i oscillations. Caffeine (30 mmol/L) alone had no effect on resting [Ca2+]i. However, [Ca2+]i oscillations in response to PE were completely inhibited when caffeine was added to the superfusate, and the oscillations returned when caffeine was washed out (Fig 9Down). The membrane-permeabilizing agent, ionomycin (5 µmol/L), was used to investigate the efficacy of caffeine to deplete SR Ca2+ stores. In the absence of extracellular Ca2+, any increase in the fluorescence signal in response to ionomycin should reflect the release of Ca2+ from intracellular stores. Fig 10Down, top, demonstrates that in the absence of extracellular Ca2+, ionomycin stimulates a large [Ca2+]i transient, reaching a peak fluorescence ratio of 10.3±0.9 (n=11 cells). Fig 10Down, bottom, shows that although caffeine abolishes PE-induced [Ca2+]i oscillations, ionomycin stimulates a [Ca2+]i transient similar in magnitude to that observed in the absence of caffeine (peak fluorescence ratio, 10.5±0.7; n=8 cells).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 9. A representative trace depicting the effect of caffeine on [Ca2+]i oscillations induced by PE. Caffeine (30 mmol/L) was added to the superfusion buffer in the continued presence of PE (10 µmol/L). After washout of caffeine, PE-induced oscillations in [Ca2+]i returned. No change in baseline [Ca2+]i was observed in response to caffeine itself (n=12 cells).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 10. Effect of caffeine (Caff) on ionomycin (Iono)–releasable Ca2+ stores in PASMCs. Top, A typical trace depicting the effect of Iono on [Ca2+]i in a single PASMC. PE was washed out of the bath using Ca2+-free buffer containing EGTA (1 mmol/l). Iono (5 µmol/L) was added where indicated on the graph. Bottom, A typical trace depicting the effect of Iono on [Ca2+]i in a single PASMC after pretreatment with Caff. After addition of Caff (30 mmol/L), the cell was perfused with Ca2+-free buffer containing both EGTA (1 mmol/L) and Caff (10 mmol/L). Iono (5 µmol/L) was added where indicated in the figure.

Ryanodine was also used to investigate the role of the SR Ca2+ store. After establishment of PE-induced [Ca2+]i oscillations, PE was washed out, and ryanodine (1 to 100 µmol/L) was added. In some cells (8 of 13 studied), addition of ryanodine (5 µmol/L) resulted in a slow increase in the resting level of [Ca2+]i in PASMCs (Fig 11Down, top), whereas in other cells (5 of 13 studied), no increase was observed. In either case, when PE was reintroduced into the bath in the continued presence of ryanodine, [Ca2+]i oscillations returned and were not significantly different in amplitude or frequency compared with the [Ca2+]i oscillations observed in the absence of ryanodine (Fig 11Down, bottom). Higher concentrations of ryanodine (100 µmol/L) did not alter baseline [Ca2+]i and had no effect on the oscillations. Ryanodine (5 µmol/L), like caffeine (Fig 10Up, bottom) had no significant inhibitory effect on ionomycin-releasable Ca2+ stores (Fig 12Down).



View larger version (30K):
[in this window]
[in a new window]
 
Figure 11. Effect of ryanodine (Ryan) on [Ca2+]i oscillations induced by PE. Top, A typical trace depicting the effect of ryanodine (5 µmol/L) alone on baseline [Ca2+]i and in the presence of PE-induced (10 µmol/L) [Ca2+]i oscillations. In the presence of PE-induced [Ca2+]i oscillations, Ryan (5 and 100 µmol/L) was added to the superfusate (n=13 cells). Bottom, Summarized data showing the effect of Ryan on amplitude and frequency of [Ca2+]i oscillations induced by PE.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 12. Effect of ryanodine on ionomycin (Iono)–releasable Ca2+ stores in PASMCs. In the presence of extracellular Ca2+ (2.5 mmol/L), cells were treated with vehicle (dimethyl sulfoxide [DMSO]) (top) or ryanodine (5 µmol/L) (bottom) for 5 minutes where indicated in the figure. The buffer was then rapidly exchanged to a Ca2+-free buffer, followed by addition of Iono (5 µmol/L) as indicated. Similar results were obtained in six cells.

We also examined whether inhibition of the SR Ca2+ pump with thapsigargin altered PE-induced [Ca2+]i oscillations. Fig 13Down demonstrates that addition of thapsigargin (1 µmol/L) in the continued presence of PE resulted in an immediate increase in the fluorescence ratio, which only partially returned to baseline. In addition, the [Ca2+]i oscillations induced by PE were abolished. Similar results were observed in nine cells.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 13. Effect of thapsigargin (Tg) on [Ca2+]i oscillations induced by PE. A typical trace depicting the effect of Tg (1 µmol/L) on PE-induced (10 µmol/L) [Ca2+]i oscillations. In the presence of PE-induced [Ca2+]i oscillations, Tg (1 µmol/L) was added to the superfusate. Similar results were obtained in nine cells.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
The present study demonstrates that PE stimulates constant, repetitive, transient increases in [Ca2+]i (Ca2+ oscillations) in cultured and freshly dispersed canine PASMCs. These oscillations are mediated through {alpha}1-adrenoceptor activation, as demonstrated by the inhibition of the oscillations by the {alpha}1-adrenoceptor antagonist prazosin. The Ca2+ oscillations require extracellular Ca2+ but do not require the activation of VOCs. Both the amplitude and the frequency of the PE-induced Ca2+ oscillations are dose dependent. Phospholipase C inhibition reduces the Ca2+ oscillations in a dose-dependent manner. The maintenance of the oscillations also depends on IP3-dependent stores of Ca2+ and the activity of the SR Ca2+ pump but does not involve Ca2+ release via the ryanodine release channel or activation of protein kinases.

Use of Cultured Cells to Study Ca2+ Signaling in Vascular Smooth Muscle
It is well known that vascular smooth muscle cells undergo spontaneous changes in their morphological and functional properties when grown in culture.21 Cultured cells may be classified into either a nonproliferating "contractile" state or a proliferating "synthetic" state.22 In addition to these structural changes, alterations in Ca2+ signaling are also known to occur in cultured cells.23 Therefore, studies using cultured vascular smooth muscle cell models to investigate Ca2+ signaling may not necessarily represent the Ca2+ signaling pathways that are active in native cells. However, because both phenotypes are also found in the vessel wall after vascular injury and in atherosclerotic lesions,24 studies carried out in both cultured and/or freshly dispersed cells can provide important information about cellular regulation in vascular smooth muscle. Cultured PASMCs were predominantly used in the present study. In addition, we used freshly dispersed PASMCs to confirm the physiological relevance of our findings.

PE-Induced Ca2+ Oscillations Are Dose Dependent
The Ca2+ response to {alpha}1-adrenoceptor activation reported in the present study differs from that observed in rat tail arterial smooth muscle cells and cat pulmonary arterial myocytes, where {alpha}1-adrenoceptor activation induced an initial peak, followed by a sustained plateau of [Ca2+]i.25 26 A recent study using freshly dispersed rat PASMCs demonstrated that angiotensin II stimulated three to six Ca2+ oscillations of constant duration but of decreasing amplitude,7 a pattern different from that observed in the present study. The pattern of Ca2+ oscillations observed in the present study is similar, although not identical, to the oscillations reported in various other cell types, such as rat hepatocytes,27 endothelial cells,28 and human uterine arterial smooth muscle cells.29 The Ca2+ oscillations in those cell types were comparable in frequency (0.7 to 1.4 min-1) and in peak [Ca2+]i (500 to 700 nmol/L) to those observed in the present study. The frequency of oscillations has been shown to depend on external conditions, particularly the concentration of the agonist,27 29 30 although it has been reported that angiotensin II–induced Ca2+ oscillations were independent of the agonist concentration.7 Our results clearly demonstrate that the amplitude and frequency of PE-induced Ca2+ oscillations increased in a dose-dependent manner in PASMCs.

Extracellular Ca2+ Is Required
PE-induced Ca2+ oscillations in canine PASMCs depend on extracellular Ca2+, because removal of external Ca2+ by EGTA resulted in an inhibition of repetitive Ca2+ oscillations. Extracellular Ca2+ was also required for the maintenance of Ca2+ oscillations induced by ATP in porcine aortic smooth muscle cells31 and by histamine in human endothelial cells.28 In contrast, angiotensin and histamine induced Ca2+ oscillations in the absence of extracellular Ca2+ in systemic arterial smooth muscle cells.7 29 Similar results were observed in BC3H-1 cells in response to PE and histamine.6 Therefore, depending on the cell type and the agonist, some cells require extracellular Ca2+ for the oscillatory behavior, and some do not. Because Ca2+ oscillations in the present study slowly diminished after removal of extracellular Ca2+ from the superfusion buffer, it is possible that extracellular Ca2+ serves as a source of Ca2+ for priming or refilling of the intracellular Ca2+ stores.

VOCs Are Not Involved
Despite our electrophysiological confirmation that VOCs are present in PASMCs, neither verapamil nor nifedipine altered the PE-induced Ca2+ oscillations. These results indicate that VOCs are not involved in the regulation of these oscillations and that extracellular Ca2+ must enter the cytosol via another route, such as receptor-operated Ca2+ channels or a passive leak. Agonist-induced Ca2+ influx was not blocked by dihydropyridines in DDT1 smooth muscle cells32 or in porcine aortic smooth muscle cells.31 Neither verapamil nor nicardipine had any significant effect on spontaneous Ca2+ oscillations in guinea pig ileum smooth muscle cells.33 In contrast, spontaneous Ca2+ oscillations in A7r5 cells were abolished by the addition of nimodipine, which suggests that Ca2+ entry through VOCs was required for Ca2+ oscillations in that cell type.34

Ca2+ Oscillations Depend on Phospholipase C Activation
Inhibition of the oscillations by U73122 indicates that IP3 and/or DG, the product of phospholipase C activation, is involved in mediating these oscillations. This finding is similar to a previous study in which U73122 inhibited Ca2+ oscillations elicited by cholecystokinin and carbachol in pancreatic acinar cells.18 Thapsigargin has been shown to increase [Ca2+]i by inhibiting the Ca2+-ATPase on intracellular stores19 and has been used to demonstrate specificity of U73122 actions in pancreatic acinar cells.18 Inhibition of the SR Ca2+ pump with thapsigargin resulted in an increase in [Ca2+]i in the presence of U73122, which indicates that U73122 did not interfere with the storage or release of intracellular Ca2+. These results indicate that the initiation and/or maintenance of Ca2+ oscillations induced by PE could be mediated either by IP3 and/or activation of PKC by DG.

Protein Kinases Are Not Involved
Activation of PKC can result in phosphorylation of specific substrate proteins, including ion channels and receptors,35 as well as contractile proteins.36 PE has been shown to elicit translocation of PKC and shortening in ferret vascular smooth muscle cells.37 Prolongation of the falling phase of each Ca2+ spike induced by PE or vasopressin has been reported in staurosporine-pretreated rat hepatocytes, suggesting the involvement of PKC in the negative-feedback control of Ca2+ spiking.38 In contrast, Ca2+ oscillations were observed in fibroblasts (REF52 cell line) in which PKC was downregulated with phorbol esters, indicating that PKC was not essential for the maintenance of these oscillations.39 In the present study, the nonspecific kinase inhibitor, staurosporine,40 inhibited both the amplitude and frequency of Ca2+ oscillations. However, this inhibitory effect was small (<10%), even at the highest concentration of staurosporine used in the present study. Therefore, it is unlikely that activation of any kinase, including PKC, plays a prominent role as a regulator of Ca2+ oscillations induced by PE in PASMCs.

Ca2+ Oscillations Depend on Caffeine-Sensitive Intracellular Ca2+ Release
Our results suggest that although extracellular Ca2+ is a prerequisite for the maintenance of the oscillations, IP3-stimulated Ca2+ release from the SR may be the key messenger that generates Ca2+ oscillations in canine PASMCs. Our observation that caffeine reversibly abolished PE-induced Ca2+ oscillations suggests the involvement of SR Ca2+ stores. These findings are consistent with caffeine-inhibiting Ca2+ spike generation evoked by IP3 in mouse pancreatic acinar cells41 and in Xenopus oocytes.42 However, caffeine itself did not increase [Ca2+]i in PASMCs. These findings are in contrast to caffeine-triggered Ca2+ responses in smooth muscle cells isolated from rat pulmonary artery,7 as well as bovine and porcine coronary artery,43 yet are similar to responses measured in other types of cultured vascular smooth muscle cells.44 45 This raises the question as to whether SR Ca2+ stores were effectively depleted by caffeine or whether caffeine has some other mechanism of action. The presence of ionomycin-releasable Ca2+ stores after caffeine pretreatment suggests that caffeine does not deplete intracellular Ca2+ stores in PASMCs. Caffeine has been shown to dose-dependently inhibit IP3-gated channel activity in cerebellar and skeletal muscle microsomes, with complete inhibition occurring with 10 mmol/L caffeine (Bezprozvanny et al46 ). A decrease in IP3 binding was also observed in the study of Bezprozvanny et al. In pancreatic acinar cells, caffeine inhibited agonist-induced production of IP3, with maximal inhibition occurring with 10 mmol/L caffeine.47 Similar results have been obtained in PC12 cells.48 These results suggest that caffeine may have an inhibitory effect on phospholipase C activity or on some intermediate step in the coupling between receptor stimulation and phospholipase C activation. Therefore, the effects of caffeine may be less specific than previously expected, and caffeine may have effects on IP3 release and/or IP3 binding in cultured PASMCs.49

Ryanodine Does Not Inhibit Ca2+ Oscillations
Ryanodine was used to gain further insight into the role of SR Ca2+ stores in PE-induced Ca2+ oscillations. Ryanodine, which opens or closes its receptor/channel on SR depending on the concentration,50 stimulated a slow increase in [Ca2+]i at a concentration of <10 µmol/L in 60% of the cells studied, suggesting that the ryanodine-sensitive Ca2+ store exists in canine PASMCs. The net effect of ryanodine on [Ca2+]i depends on other intracellular Ca2+–removal processes, including the sarcolemmal Ca2+ pump and the Na+-Ca2+ exchanger. It is possible that these intracellular Ca2+–removing processes were unable to keep up with the Ca2+ being released from the SR in response to ryanodine treatment in PASMCs, which could account for the sustained increase in baseline [Ca2+]i. A ryanodine-induced sustained increase in [Ca2+]i has been reported in both cardiac51 and smooth muscle43 52 preparations. In coronary artery smooth muscle cells,43 ryanodine (10 µmol/L) caused a sustained increase in [Ca2+]i above baseline. This effect was found to be due to both ryanodine-induced release of Ca2+ from the SR and inhibition of Ca2+ efflux via a reduction in the activity of the Na+-Ca2+ exchanger.43 Thus, the sustained increase in [Ca2+]i observed in most cells in the present study is consistent with previously reported effects of ryanodine in vascular smooth muscle cells.

Despite variability in the actions of ryanodine on baseline Ca2+, ryanodine (1 to 100 µmol/L) had no effect on either the frequency or amplitude of PE-induced Ca2+ oscillations when PE was reintroduced into the perfusate. These data suggest that either ryanodine-sensitive stores are not involved in the oscillations or that in the presence of extracellular Ca2+, the SR may be capable of refilling sufficiently rapidly to keep up with ryanodine-induced SR Ca2+ loss through channels locked in their subconductance state. Alternatively, ryanodine release channels may be scarce in cultured PASMCs. In the present study, ryanodine (5 µmol/L) failed to alter Ca2+ oscillations and ionomycin-releasable Ca2+ pools when extracellular Ca2+ was present. Because the oscillations were dependent on the presence of extracellular Ca2+ (Fig 4Up), a protocol to test the actions of ryanodine on Ca2+ oscillations or ionomycin-releasable Ca2+ stores in the absence of extracellular Ca2+ was not feasible. These data do not rule out the possibility of rapid refilling of the SR from extracellular Ca2+ sources but more likely support our caffeine data and the notion that there are not many ryanodine-sensitive channels present in cultured PASMCs. This would be consistent with the findings of others demonstrating the loss of caffeine-triggered Ca2+ transients in smooth muscle cells after only 3 days in culture.23 Under culture conditions, the relative importance of Ca2+-induced Ca2+ release may be reduced, and it is unlikely that many ryanodine-sensitive Ca2+ release channels are present in these PASMCs.

Confirmation that the SR is directly involved in the Ca2+ oscillations is provided by the results obtained with thapsigargin. Thapsigargin, which blocks the SR Ca2+-ATPase, resulting in the inability of the SR to sequester Ca2+, completely blocked the Ca2+ oscillations. These results suggest that refilling of a SR Ca2+ pool by the Ca2+-ATPase is required for maintenance of the oscillations. Therefore, it appears that the ryanodine receptor, if present, plays a minor role in the oscillations, whereas caffeine-sensitive Ca2+ stores and refilling of these stores by the SR Ca2+-ATPase may play a major role in the oscillations.

Ca2+ Oscillations in Cell Signaling
Although speculative, it is possible that individual cell types display unique oscillatory patterns ("fingerprints" or "signatures"), which may represent an encoded signal to alter cell function.30 The frequency of Ca2+ oscillations could be an important factor in the modulation of smooth muscle cell contractility and vasomotor tone in response to {alpha}1-adrenoceptor stimulation. Such oscillations may represent a digitization of the Ca2+ signal, allowing a frequency-dependent control of the contractile response.53 Frequency-dependent signaling would provide a mechanism to "fine tune" the contractile response. Alternatively, oscillations may allow Ca2+ to function as a second messenger while obviating the adverse effects of a sustained elevation in [Ca2+]i.31 Such a sustained elevation could desensitize Ca2+-sensitive cellular response elements and/or increase energy loss due to stimulation of Ca2+-activated ATP-dependent enzymes. Because the oscillations do not depend on Ca2+ influx via VOCs, it is likely that PASMCs are not membrane oscillators but that they represent cytosolic oscillators.53 The oscillations, at least in part, could be explained by periodic formation of IP3-triggering bursts of Ca2+ release.54 However, a negative-feedback loop involving PKC does not appear to be critically involved. Alternatively, IP3 may be continuously present in the cell, and the action of IP3 could be periodic by virtue of a negative-feedback loop operated through Ca2+ itself.55 Transsarcolemmal Ca2+ influx via receptor-operated Ca2+ channels may be involved in priming or refilling the IP3 Ca2+ store. Regardless of the precise mechanism of control, Ca2+ oscillations in PASMCs may be involved in the acute modulation of vasomotor tone in response to neural, humoral, or locally derived vasoactive factors.

Summary
In summary, the major finding of the present study is that {alpha}1-adrenoceptor activation with PE triggers persistent Ca2+ oscillations in PASMCs via the phospholipase C signaling pathway. The oscillations are dependent on the presence of extracellular Ca2+ but do not require activation of voltage-operated Ca2+ channels. In addition, thapsigargin-sensitive and caffeine-sensitive, but not ryanodine-sensitive, Ca2+ stores appear to be involved. Protein phosphorylation by protein kinases is not involved in regulating the oscillations. The mechanisms that trigger and maintain these Ca2+ oscillations are complex and likely involve an interplay between multiple downstream cellular signals associated with Ca2+ regulation.


*    Selected Abbreviations and Acronyms
 
DG = diacylglycerol
IP3 = inositol 1,4,5-trisphosphate
LB = loading buffer
PASMC = pulmonary artery smooth muscle cell
PE = phenylephrine
PKC = protein kinase C
SR = sarcoplasmic reticulum
VOC = voltage-operated Ca2+ channel


*    Acknowledgments
 
This study was supported by National Heart, Lung, and Blood Institute grants HL-38291 and HL-40361. Dr Hamada was also supported by Prof Osafumi Yuge, MD, PhD, Department of Anesthesiology, Hiroshima University School of Medicine, Hiroshima, Japan. The authors gratefully acknowledge the creative efforts of Peggy Kirian in developing the protocol for isolating freshly dispersed pulmonary arterial myocytes and her expertise in performing the electrophysiological recordings. The authors would also like to thank Ronnie Sanders for outstanding work in preparing this manuscript.

Received January 9, 1997; accepted July 18, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Clapp LH, Gurney AM. ATP-sensitive K+ channels regulate resting potential of pulmonary arterial smooth muscle cells. Am J Physiol. 1992;262:H916-H920.[Abstract/Free Full Text]
  2. Yuan X-J. Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in pulmonary arterial myocytes. Circ Res. 1995;77:370-378.[Abstract/Free Full Text]
  3. Minneman KP, Esbenshade TA. {alpha}1-Adrenergic receptor subtypes. Annu Rev Pharmacol Toxicol. 1994;34:117-133.[Medline] [Order article via Infotrieve]
  4. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature. 1993;361:315-325.[Medline] [Order article via Infotrieve]
  5. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;258:607-614.[Abstract/Free Full Text]
  6. Ambler SK, Poenie M, Tsien RY, Taylor P. Agonist-stimulated oscillations and cycling of intracellular free calcium in individual cultured muscle cells. J Biol Chem. 1988;263:1952-1959.[Abstract/Free Full Text]
  7. Guibert C, Marthan R, Savineau JP. Angiotensin II-induced Ca2+-oscillations in vascular myocytes from the rat pulmonary artery. Am J Physiol. 1996;270:L637-L642.[Abstract/Free Full Text]
  8. Hyman AL, Kadowitz PJ. Evidence for existence of postjunctional {alpha}1- and {alpha}2-adrenoceptors in cat pulmonary vascular bed. Am J Physiol. 1985;249:H891-H898.
  9. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Ridden C, Kealey T. {alpha}-Adrenoceptor stimulation of porcine pulmonary arteries. Eur J Pharmacol. 1993;235:169-175.[Medline] [Order article via Infotrieve]
  10. Yamaguchi T, Rodman D, O'Brien R, McMurtry I. Modulation of pulmonary artery contraction by endothelium-derived relaxing factor. Eur J Pharmacol. 1989;161:259-262.[Medline] [Order article via Infotrieve]
  11. Campbell JH, Campbell GR. Culture techniques and their applications to studies of vascular smooth muscle. Clin Sci. 1993;85:501-513.[Medline] [Order article via Infotrieve]
  12. Albarwani S, Heinert G, Turner JL, Kozlowski RZ. Differential K+ channel distribution in smooth muscle cells isolated from the pulmonary arterial tree of the rat. Biochem Biophys Res Commun. 1995;208:183-189.[Medline] [Order article via Infotrieve]
  13. Subramanian M, Madden JA, Harder DR. A method for the isolation of cells from arteries of various sizes. J Tissue Culture Methods. 1991;13:13-19.
  14. Goldman WF, Bova S, Blaustein MP. Measurement of intracellular Ca2+ in cultured arterial smooth muscle cells using fura-2 and digital imaging microscopy. Cell Calcium. 1990;11:221-231.[Medline] [Order article via Infotrieve]
  15. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.[Abstract/Free Full Text]
  16. Ambler SK, Taylor P. Mobilization of intracellular calcium by alpha 1-adrenergic receptor activation in muscle cell monolayers. J Biol Chem. 1986;261:5866-5871.[Abstract/Free Full Text]
  17. Brown RD, Berger KD, Taylor P. Alpha 1-adrenergic receptor activation mobilizes cellular Ca2+ in a muscle cell line. J Biol Chem. 1984;259:7554-7562.[Abstract/Free Full Text]
  18. Yule DI, Williams JA. U73122 inhibits Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J Biol Chem. 1992;267:13830-13835.[Abstract/Free Full Text]
  19. Thastrup O, Cullen PJ, Drbak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci U S A. 1990;87:2466-2470.[Abstract/Free Full Text]
  20. Hoffman R, Newlands ES. Role of protein kinase C in adriamycin-induced erythroid differentiation of K562 cells. Cancer Chemother Pharmacol. 1991;28:102-104.[Medline] [Order article via Infotrieve]
  21. Campbell JH, Campbell GR. Endothelial cell influences on vascular smooth muscle phenotype. Annu Rev Physiol. 1997;48:295-306.[Medline] [Order article via Infotrieve]
  22. Chamley-Campbell JH, Campbell GR. The smooth muscle cell in culture. Atherosclerosis. 1981;40:347-357.[Medline] [Order article via Infotrieve]
  23. Masuo M, Toyo-oka T, Shin WS, Sugimoto T. Growth-dependent alterations of intracellular Ca2+-handling mechanisms of vascular smooth muscle cells: PDGF negatively regulates functional expression of voltage-dependent, IP3-mediated, and Ca2+-induced Ca2+ release channels. Circ Res. 1991;69:1327-1339.[Abstract/Free Full Text]
  24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.[Medline] [Order article via Infotrieve]
  25. Li XF, Kargacin ME, Triggle CR. The effects of {alpha}-adrenoreceptor agonists on intracellular Ca2+ levels in freshly dispersed single smooth muscle cells from rat tail artery. Br J Pharmacol. 1993;109:1272-1275.[Medline] [Order article via Infotrieve]
  26. Vadula MS, Kleinman JG, Madden JA. Effect of hypoxia and norepinephrine on cytoplasmic free Ca2+ in pulmonary and cerebral arterial myocytes. Am J Physiol. 1993;265:L591-L597.[Abstract/Free Full Text]
  27. Woods NM, Cuthbertson KSR, Cobbold PH. Repetitive transient rises in cytoplasmic free calcium in hormone-stimulated hepatocytes. Nature. 1986;319:600-602.[Medline] [Order article via Infotrieve]
  28. Jacob R, Merritt JE, Hallam TJ, Rink TJ. Repetitive spikes in cytoplasmic calcium evoked by histamine in human endothelial cells. Nature. 1988;335:40-45.[Medline] [Order article via Infotrieve]
  29. Nicholls JA, Greenwell JR, Gillespie JI. Agonist concentration influences the pattern and time course of intracellular Ca2+ oscillations in human arterial smooth muscle cells. Pflugers Arch. 1995;429:477-484.[Medline] [Order article via Infotrieve]
  30. Prentki M, Glennon MC, Thomas AP, Morris RL, Matschinsky FM, Corkey BE. Cell-specific patterns of oscillating free Ca2+ in carbamylcholine-stimulated insulinoma cells. J Biol Chem. 1988;263:11044-11047.[Abstract/Free Full Text]
  31. Mahoney MG, Randall CJ, Linderman JJ, Gross DJ, Slakey LL. Independent pathways regulate the cytosolic [Ca2+] initial transient and subsequent oscillations in individual cultured arterial smooth muscle cells responding to extracellular ATP. Mol Biol Cell. 1992;3:493-505.[Abstract]
  32. Reynolds EE, Dubyak GR. Agonist-induced calcium transients in cultured smooth muscle cells: measurements with fura-2 loaded monolayers. Biochem Biophys Res Commun. 1986;136:927-934.[Medline] [Order article via Infotrieve]
  33. Ohata H, Kawanishi T, Kawanishi M, Uneyama C, Takahashi M, Momose K. Spontaneous oscillations of cytoplasmic free calcium ion concentration in cultured smooth muscle cells from guinea pig ileum. Jpn J Pharmacol. 1993;63:83-91.[Medline] [Order article via Infotrieve]
  34. Byron KL, Taylor CW. Spontaneous Ca2+ spiking in a vascular smooth muscle cell line is independent of the release of intracellular Ca2+ stores. J Biol Chem. 1993;268:6945-6952.[Abstract/Free Full Text]
  35. Shearman MS, Sekiguchi K, Nishizuka Y. Modulation of ion channel activity: a key function of the protein kinase C enzyme family. Pharmacol Rev. 1989;41:211-237.[Abstract]
  36. Rasmussen H, Takuwa Y, Park S. Protein kinase C in the regulation of smooth muscle contraction.